Top Equity Markets in 4Q23

In the fourth quarter of 2023, performance for equity markets was generally strong across the board, with the exception of three markets. Here, we present the best and worst performing markets for 4Q23 and their respective outlooks for the year ahead.

Zheng Bolun
Zheng Bolun10 Jan 2024 2004 Views
Top Equity Markets in 4Q23

• Global equities had put up a strong performance in 4Q23, with the MSCI ACWI Index gaining +7.32% (in SGD terms).

Brazil: A supportive monetary policy backdrop, a new fiscal framework to improve fiscal balances and a positive outlook for commodities bodes well for Brazil’s economy and corporate earnings.

Taiwan: An uptick in the global semiconductor industry, and a rebound in exports growth has improved investor sentiments.

China: China’s economy would continue to struggle, with consumer and business confidence remaining low, on top of a struggling real estate sector which would weigh on its growth.

Hong Kong: Similar to China, we believe that ongoing economic and geopolitical risks would persist and dampen economic and corporate earnings growth.


Global equity markets closed off 2023 on a strong note, with most of them in the green across both developed and developing markets, and the MSCI ACWI index gaining by 7.32% (in SGD terms) in 4Q23.

On a single market level, the best performing markets in 4Q23 (in SGD terms) were Brazil (+14.67%) and Taiwan (+11.83%). On the other spectrum, the bottom performing markets were China (-7.53%) and Hong Kong (-6.97%).


Figure 1: 4Q23 global equities performance ranked (regions under coverage)


Brazil (+14.67% in SGD terms)

What drove 4Q23 performance?

Brazil’s equity market performed well in 4Q23, rising by +14.67% (in SGD terms), and rebounding from the -4.57% decline in 3Q23. The decision to loosen monetary policy by the Central Bank of Brazil creates a supportive backdrop for equities, especially at a time when central banks from other developed nations have yet to cut interest rates. Furthermore, Brazil’s economy also expanded more strongly than anticipated, with upwards revisions to its GDP, which improves investor sentiments and resulted in equity inflows.

Equity outlook:

Looking ahead, besides a supportive monetary policy backdrop, policy concerns have also moderated, with Brazil's lower house having approved a new fiscal framework proposed by President Luiz Inacio Lula da Silva, which is moving towards improving fiscal balances. Next, due to the region’s outsized influence by commodity prices, a positive outlook for commodities would also benefit Brazil’s economic growth and corporate earnings.

For instance, the medium to long-term outlook for green metals continues to look attractive, as the energy transition becomes a priority and represents a significant driver of incremental demand for copper, nickel, lithium, and other metals which are essential in renewable technologies.

Related article: Brazil: Look to this attractive market to outperform again


Figure 2: BOVESPA Index price vs EPS chart


Table 1: EPS and projections for BOVESPA Index

Brazil (BOVESPA Index)

2022

2023E

2024E

2025E

PE Ratio (X)

5.81

9.67

8.79

8.37

Earnings Growth

17.0%

-38.0%

10.0%

5.0%

EPS

18,873

11,701

12,871

13,515

Target Price (Based on fair PE ratio of 11.5X)

-

-

-

155,417

Upside Potential

-

-

-

15.8%

Source: Bloomberg Finance L.P., iFAST Compilations.
Data as of 31 Dec 2023


Table 2: Recommended products

ETF

Unit Trusts

Brazil

iShares MSCI Brazil ETF (NYSE:EWZ)

JPM Brazil Equity A (acc) SGD Fund


Taiwan (+11.93% in SGD terms)

What drove 4Q23 performance?

Taiwan’s equity market also performed well in 4Q23, gaining +11.93% (in SGD terms), rebounding from the -4.06% decline in 3Q23. Given that Taiwan produces over 60% of the world’s semiconductors and over 90% of the most advanced chips, signs that the global semiconductor industry is heading into an upcycle have buoyed investment sentiments. Furthermore, given that Taiwan’s economy is export-oriented with exports accounting for around 70% of total GDP, an upturn in exports growth has also improved its growth outlook.

Equity outlook:

As the world becomes increasingly digitalised, the demand for chips is expected to continue to rise. The surge in demand for semiconductors is anticipated to be driven largely by the widespread adoption of artificial intelligence (AI), reminiscent of the impact seen during past technological advancements such as the PC, smartphone, and the internet. 

We expect Taiwan to experience substantial gains from the recovery in the semiconductor industry, especially with companies like TSMC leading as the primary choice for state-of-the-art chip manufacturing. Nevertheless, we also acknowledge the geopolitical risks in Taiwan, and escalating tensions could trigger a sell-off in Taiwanese equities.

Related article: Will the prospects of Asian equities improve after an underwhelming year?


Figure 3: TWSE Index price vs EPS chart


Table 3: EPS and projections for TWSE Index

Taiwan (TWSE Index)

2022

2023E

2024E

2025E

PE Ratio (X)

13.2

17.6

15.3

13.9

Earnings Growth

13.2%

-25.0%

15.0%

10.0%

EPS

1,362

1,021

1,174

1,292

Target Price (Based on fair PE ratio of 17X)

-

-

-

21,964

Upside

-

-

-

22.5%

Source: Bloomberg Finance L.P., iFAST Compilations.
Data as of 31 Dec 2023


Table 4: Recommended products

ETF

Unit Trusts

Taiwan

iShares MSCI Taiwan ETF (NYSE:EWT)

-


China (-7.53% in SGD terms)

What drove 4Q23 performance?

China was the worst performer. Its equity market continued its slump in 4Q23, losing -7.53% (in SGD terms) after a -0.81% decline in 3Q23. This is on the back of fragile consumer and business confidence, which weakens investor sentiments. Furthermore, China’s property market is faced with persistent challenges, and is anticipated to decline further due to sluggish purchasing demand. 

Equity outlook:

Besides the ongoing economic pain points, there are also longer-term structural issues to worry about, particularly China’s embrace of a top-down state-controlled growth model and a deterioration in US-China relations. While we expect a more expansionary fiscal stance and further relaxation of the monetary policy regime in 2024, we believe that it will take time to observe the effectiveness of these policies. All in all, we believe that China is in a structural decline, and in the absence of any significant reforms, a quick turnaround is unlikely.

Due to geopolitical uncertainty and a weakening economic landscape, we believe it is important for investors to align their portfolios with China’s priorities: that means investing more in SOEs and companies that operate in favoured industries (e.g. green energy, electric vehicles, and advanced manufacturing). Most of these companies are found in the A-shares market, which should be relatively more resilient compared to the offshore market where foreign investor confidence remains fragile. Therefore, investors that still interested in investing in China can consider either the E-Fund CSI 300 ETF (SSE:510310) or the Allianz China A Shares Fund.

Related article: Riding the Chinese dragon in 2024? It’s no easy feat!


Figure 4: MXCN Index price vs EPS chart


Table 5: EPS and projections for MCXN Index

China (MSCI China Index)

2022

2023E

2024E

2025E

PE Ratio (X)

12.2

11.7

11.2

10.4

Earnings Growth

-16.6%

1.4%

3.2%

6.8%

EPS

4.6

4.8

5.0

5.4

Target Price (Based on fair PE ratio of 10X)

-

-

-

53.8

Upside Potential

-

-

-

-3.8%

Source: Bloomberg Finance L.P., iFAST Compilations.
Data as of 31 Dec 2023


Table 6: Recommended products

ETF

Unit Trusts

China

E-Fund CSI 300 ETF (SSE:510310)

Allianz China A Shares AT Acc SGD Fund



Hong Kong (-6.97% in SGD terms)

What drove 4Q23 performance?

Hong Kong’s equity market also continued its downward trajectory in 4Q23, declining by -6.97% (in SGD terms), after a -3.11% decline in 3Q23. Since there is a strong overlap between the Hang Seng index and the MSCI China index, a weak performance by constituents in the Chinese market also resulted in poor performance for Hong Kong’s market.

Equity outlook:

Similar to our outlook for China, we continue to hold a negative view on the Hong Kong markets, given the murky economic climate and ongoing geopolitical tensions. While the government has pledged more stimulus measures, they are far from being a game changer. Without large targeted reforms that will put Hong Kong’s economy on a more sustainable growth path, the lack of new growth drivers, coupled with weak imports and exports, would continue to weigh on corporate earnings and the region’s growth prospects.

Nevertheless, if investors wish to invest in the Hong Kong equity market, they can consider the Tracker Fund of Hong Kong (HKEX:2800).


Figure 5: HSI Index price vs EPS chart


Table 7: EPS and projections for HSI Index

Hong Kong (HSI Index)

2022

2023E

2024E

2025E

PE Ratio (X)

9.4

8.9

8.7

8.4

Earnings Growth

-7.0%

5.0%

3.0%

3.0%

EPS

1,819

1,910

1,968

2,027

Target Price (Based on fair PE ratio of 9X)

-

-

-

18,241

Upside Potential

-

-

-

7.0%

Source: Bloomberg Finance L.P., iFAST Compilations.
Data as of 31 Dec 2023


Table 8: Recommended products

ETF

Unit Trusts

Hong Kong

Tracker Fund of Hong Kong (HKEX:2800)

-



Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.



All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.